Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.11.001
Abstract: BACKGROUND Clinical benefit has not been evaluated much in patients with nocturia. OBJECTIVE To assess the clinical benefit of desmopressin orally disintegrating tablet (ODT) in women (25μg) and men (50μg) with nocturia due to nocturnal… read more here.
Keywords: clinical benefit; benefit; patients nocturia; desmopressin orally ... See more keywords